Evidence map›Paper›PMID 42686762›Full record

ArticleNature communications2026

Three-site cycloadditions within one reaction intermediate with site-selectivity controlled by electronic and size bias.

Chandrima Maitra, Debashis Barik, Ting-You Wu, Chia-Jung Yang, Mu-Jeng Cheng, William A Goddard, Rai-Shung Liu

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chandrima Maitra *Department of Chemistry, National Tsing-Hua University, Hsinchu, Taiwan, ROC.ORCID http://orcid.org/0000-0003-4430-8325
Debashis Barik *Department of Chemistry, National Tsing-Hua University, Hsinchu, Taiwan, ROC.ORCID http://orcid.org/0000-0002-0652-3932
Ting-You WuDepartment of Chemistry, National Cheng Kung University, Tainan, Taiwan, ROC.
Chia-Jung YangDepartment of Chemistry, National Cheng Kung University, Tainan, Taiwan, ROC.
Mu-Jeng ChengDepartment of Chemistry, National Cheng Kung University, Tainan, Taiwan, ROC. mjcheng@mail.ncku.edu.tw.ORCID http://orcid.org/0000-0002-8121-0485
William A GoddardDepartment of Chemistry, Materials and Process Simulation Center, California Institute of Technology, Pasadena, CA, USA. wag@caltech.edu.ORCID http://orcid.org/0000-0003-0097-5716
Rai-Shung LiuDepartment of Chemistry, National Tsing-Hua University, Hsinchu, Taiwan, ROC. rsliu@mx.nthu.edu.tw.ORCID http://orcid.org/0000-0002-2011-8124

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In homogeneous catalysis, a reaction intermediate typically possesses only one reactive site to ensure chemoselectivity. However, such a design limits efficiency and requires multiple independent steps to achieve divergent synthesis. What if a single intermediate could act as a "master key" featuring multiple, differentiated sites that each respond selectively to distinct partners? This concept has remained largely unexplored due to the long-standing challenge of controlling site selectivity. Here, we report the design of a remarkable three-site intermediate (Int-1) that serves as a selective, programmable hub for complex molecular synthesis. Using a gold catalyst and 1,6-allenynes, we generate an intermediate containing three sterically and electronically distinct cycloaddition sites (A, B, and C). The power of this intermediate lies in its intelligent site recognition: site-A reacts exclusively with bulky dipolarophiles, site-B selectively traps nucleophilic partners, and site-C engages electrophilic aldehydes. This precise multi-site control, rationalized by DFT calculations, enables three divergent cycloaddition pathways to proceed from a common intermediate. The discovery of three-site intermediate Int-1 establishes a new paradigm for multi-site divergent synthesis, providing a one-step platform for the efficient generation of structurally diverse benzoxepines-the core scaffolds of numerous bioactive molecules and pharmaceuticals.

Identifiers

PMID42686762
PMCPMC13538594

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.